Archive | Study Focus RSS for this section

STUDY: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors (Alliance for Clinical Trials in Oncology)

This randomized phase III trial compares standard-dose combination chemotherapy to high-dose combination chemotherapy with stem cell transplant to treat patients with refractory or relapsed germ cell tumours.  

  •  Age Eligibility: 14 years and over
  • NOL Date: Canadian NOL June 1, 2016
  • Cooperative Group: Alliance for Clinical Trials in Oncology, sponsored in Canada by C17 for pediatric centres
  • NCT02375204, Alliance Protocol A031102
  • https://clinicaltrials.gov/ct2/show/NCT02375204